Novo Nordisk's diet drug Wegovy oral tablets were approved by the European Commission and became the EU's first oral GLP‑1 drug for weight management; its 7.2 mg high-dose disposable ready-to-use syringe was approved at the same time.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.